Mox Card IV 400mg Infusion
Marketer
Cucard Pharma
Salt Composition
Moxifloxacin (400mg)
Overview Mox Card IV 400mg Infusion
Cefixime 400mg intravenous infusion is a broad-spectrum antibiotic indicated for various bacterial infections. These include urinary tract infections, respiratory infections (including pneumonia), and infections affecting the skin, soft tissues, nose, and throat. Its mechanism of action involves inhibiting bacterial growth, thereby resolving the infection. Administered intravenously by a healthcare professional, this injection is reserved for patients unable to take oral medication, such as those hospitalized or unconscious. Self-administration is strictly prohibited. Complete the prescribed course, even with symptom improvement, to prevent relapse. Common side effects include headache, nausea, dizziness, and diarrhea. Injection site reactions such as pain, swelling, or redness may also occur; these are typically transient but warrant medical attention if persistent. While diarrhea is a potential side effect, it usually subsides upon treatment completion. Report persistent diarrhea or bloody stools immediately. Prior allergies to any constituent should be disclosed to your physician before treatment. Patients with kidney impairment require careful monitoring during therapy.
Uses of Mox Card IV 400mg Infusion
Managing bacterial infections affecting the eyes
Major Benefits of Mox Card IV 400mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mox Card IV 400mg Infusion:
- Injection site reactions (pain, swelling, redness)
- Eye discomfort
- Dry eye
- Burning sensation in eye
How to use Mox Card IV 400mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mox Card IV 400mg Infusion works:
Cefixime intravenous solution (400mg) is a bactericidal antibiotic that inhibits bacterial DNA gyrase, thus halting bacterial replication and repair mechanisms, resulting in cell death.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside a 400mg intravenous Mox Card infusion presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mox Card IV 400mg infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Administration of Mox Card IV 400mg via infusion is likely unsafe for breastfeeding mothers. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Mox Card IV 400mg Infusion may induce adverse reactions impacting driving capabilities. These reactions can manifest as dizziness, lightheadedness, brief visual disturbances, or temporary fainting episodes, potentially impairing safe driving.
KidneySAFE IF PRESCRIBED
The intravenous administration of 400mg Mox Card is considered safe for individuals with kidney impairment; no dosage modification is necessary. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advisable.
LiverCAUTION
Intravenous Mox Card 400mg should be administered cautiously to individuals with advanced hepatic impairment. Dosage modification of intravenous Mox Card 400mg may be necessary. Physician consultation is advised. Data regarding the use of intravenous Mox Card 400mg in such patients is limited. Dosage alterations are not suggested for those with mild or moderate liver dysfunction.
What if you forget to take Mox Card IV 400mg Infusion :
Omit a Mox Card IV 400mg Infusion dose? Seek your physician's advice.
Facts to Know About Mox Card IV 400mg Infusion
| Label | Value |
|---|---|
| Chemical Type | Quinolone antibiotic |
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
| Actions | Fluoroquinolone antibiotics |
3,018 People bought this recently